NCT01973374

Brief Summary

Maternal diabetes in pregnancy can negatively impact fetal well-being and contribute to adverse pregnancy outcomes. Much of the morbidity associated with diabetes in pregnancy can be minimized with tight glucose control. A number of studies in non-pregnant populations have highlighted the feasibility, acceptability and efficacy of text messaging interventions for improving diabetic compliance and control. This study will investigate whether a text messaging intervention is feasible and effective in an urban, diabetic, obstetric clinic and whether this intervention can improve compliance with diabetes care, glucose control and pregnancy outcomes. The study will also assess satisfaction with the intervention itself.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 24, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 31, 2013

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

February 20, 2015

Status Verified

February 1, 2015

Enrollment Period

1.2 years

First QC Date

October 24, 2013

Last Update Submit

February 19, 2015

Conditions

Outcome Measures

Primary Outcomes (2)

  • Patient Satisfaction

    Patient satisfaction with the texting intervention as measured by a post-study survey

    date of enrollment up to 12 weeks post partum

  • Compliance with Obstetric and Diabetes Care

    Proportion of prenatal visits attended, proportion of assigned blood glucose logs sent to clinic for review, proportion of assigned blood glucose values checked, compliance with attendance at postpartum visit.

    OB screening visit through 12 weeks postpartum

Secondary Outcomes (4)

  • Efficacy measures

    Diabetes diagnosis through 12 weeks postpartum

  • Healthcare Utilization Measures

    Screening OB visit through 12 weeks postpartum

  • Maternal Outcomes

    Delivery date through 12 weeks postpartum

  • Neonatal Outcomes

    Neonate delivery through 12 weeks postpartum

Study Arms (2)

Routine Care

NO INTERVENTION

Text Message Intervention

EXPERIMENTAL

The text message intervention group receives usual prenatal and diabetic care in addition to two text messages per week throughout the pregnancy and a reminder text message prior to the postpartum visit. The text message intervention group also fills out a survey about the intervention after delivery.

Behavioral: Text Message Intervention

Interventions

Text Message Intervention

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women aged 18-50 years
  • Planned delivery at Hospital of the University of Pennsylvania

You may not qualify if:

  • Gestational age greater than 34 weeks at initial visit in the Penn Perinatal Diabetes Program
  • Women who are unable to read English as all text messages will be in English
  • Women who do not have a cellular phone capable of receiving text messages as this is the study intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Maternal Fetal Medicine, Department of Obstetrics and Gynecology Director, Penn Perinatal Diabetes Program Director, High Risk Clinic at the Helen O. Dickens Center for Women's Health

Study Record Dates

First Submitted

October 24, 2013

First Posted

October 31, 2013

Study Start

January 1, 2013

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

February 20, 2015

Record last verified: 2015-02

Locations